In line with the inflammatory signatures, the increased IRF5 expression in the adipose tissue of diabetic obese patients has been suggested as a potential marker for metabolic inflammation in obesity/T2D [73]. The gene discussed is IRF5; the disease is obesity due to melanocortin 4 receptor deficiency.